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ARTICLE
The human Vδ2+ T-cell compartment comprises
distinct innate-like Vγ9+ and adaptive Vγ9-
subsets
Martin S. Davey 1, Carrie R. Willcox1, Stuart Hunter1,2, Sofya A. Kasatskaya3,4, Ester B.M. Remmerswaal5,
Mahboob Salim1, Fiyaz Mohammed1, Frederike J. Bemelman6, Dmitriy M. Chudakov3,4,7,8, Ye H. Oo2 &
Benjamin E. Willcox1
Vδ2+ T cells form the predominant human γδ T-cell population in peripheral blood and
mediate T-cell receptor (TCR)-dependent anti-microbial and anti-tumour immunity. Here we
show that the Vδ2+ compartment comprises both innate-like and adaptive subsets. Vγ9+
Vδ2+ T cells display semi-invariant TCR repertoires, featuring public Vγ9 TCR sequences
equivalent in cord and adult blood. By contrast, we also identify a separate, Vγ9− Vδ2+ T-cell
subset that typically has a CD27hiCCR7+CD28+IL-7Rα+ naive-like phenotype and a diverse
TCR repertoire, however in response to viral infection, undergoes clonal expansion and
differentiation to a CD27loCD45RA+CX3CR1+granzymeA/B+ effector phenotype. Consistent
with a function in solid tissue immunosurveillance, we detect human intrahepatic Vγ9− Vδ2+
T cells featuring dominant clonal expansions and an effector phenotype. These ﬁndings
redeﬁne human γδ T-cell subsets by delineating the Vδ2+ T-cell compartment into innate-like
(Vγ9+) and adaptive (Vγ9−) subsets, which have distinct functions in microbial
immunosurveillance.
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γδ T cells have coevolved alongside B cells and αβ T cells inthe vertebrate immune system for almost 450 million years1.
They provide anti-microbial2 and anti-tumour immunity3,
but whether they occupy an innate-like or adaptive immunolo-
gical niche has remained unclear. Notably, αβ T cells incorporate
a group of unconventional T cells, including mucosal-associated
invariant T (MAIT) cells and invariant natural killer T (iNKT)
cells that recognise antigens in the context of single MHC-like
proteins (MR1 and CD1d), and display a semi-invariant T-cell
receptor (TCR) repertoire, suggestive of an innate-like biology
whereby TCR sensitivity is retained but the γδ TCR may arguably
function as a surrogate pattern recognition receptor4. Notably,
studies in mice have suggested that innate-like γδ T-cell
development in the thymus can occur via distinct pathways
involving agonistic signals5. In addition, recently, Wencker et al.6
have suggested that following TCR triggering during develop-
ment, mouse innate-like T cells may transition to a state of TCR
hyporesponsiveness in which they preferentially respond to
TCR-extrinsic stimuli such as cytokine exposure.
Human γδ T cells are often delineated into Vδ2+ and Vδ2−
subsets7. Vδ2− γδ T cells have been directly implicated in anti-viral
and anti-tumour immunity3,8 and utilise germline-encoded antigen
receptors also present on innate-like lymphocytes, including
NKG2D and NKp309,10. However, recent evidence has suggested
that they may adopt a TCR-dependent adaptive immunobiology,
based on highly clonotypically focused expansions alongside dif-
ferentiation from a naive to effector phenotype11 and perturbations
in clonal expansion upon cytomegalovirus (CMV) infection in
post-stem cell transplant patients12. Conversely, Vδ2+ T cells are
arguably the prototypic unconventional T cell, typically co-
expressing Vγ9 TCR chains and representing the major γδ subset
in adult peripheral blood13. Vγ9+ Vδ2+ T cells respond to prenyl
pyrophosphate metabolites (phosphoantigens, or P-Ags) produced
either by the host mevalonate pathway (isopentenyl pyrophosphate,
IPP) or microbial non-mevalonate pathway ((E)-4-Hydroxy-3-
methyl-but-2-enyl pyrophosphate, HMB-PP)14, which are sensed in
the context of butyrophilin 3A1 (BTN3A1)15–17. They mount
important anti-microbial immune responses, including against
Mycobacterium tuberculosis13 and Plasmodium falciparum18, and
drive αβ T-cell responses19,20.
Previously, the extrathymic expansion of Vγ9+ Vδ2+ T cells
observed in adult peripheral blood, which is proposed to result
from exposure to P-Ag-producing microbes encountered after
birth21,22 and thought to involve clonotypic expansion23,24,
arguably suggests an adaptive immunobiology. However, Vγ9+
Vδ2+ T cells are highly enriched in foetal peripheral blood and
display restricted complementarity-determining region (CDR) 3
γ9 usage early in gestation25, more consistent with an innate-like
pre-natal repertoire of Vγ9+ Vδ2+ T cells.
To better understand human Vδ2+ γδ T-cell immunobiology we
carried out a dedicated analysis of their clonotypic diversity and
cellular phenotype. Our ﬁndings suggest Vδ2+ T cells can be
delineated into two discrete subsets: Vγ9+ Vδ2+ T cells adopt a
predominantly innate-like biology originating in neonatal develop-
ment and allowing a degree of clonotypic plasticity, whereas Vγ9−
Vδ2+ T cells adopt a distinct adaptive immunobiology, including
focused clonal expansions and differentiation evident both in per-
ipheral blood and solid tissues, and generated in response to acute
viral infection. These ﬁndings revise our understanding of human
γδ T cells, and prompt further investigation of the adaptive
immunity provided by the Vγ9− Vδ2+ subset.
Results
Adult and neonatal Vδ2+ T cells have similar TCR diversity.
Consistent with previous studies, we conﬁrmed that human cord
blood Vδ2+ γδ T cells were present at relatively low levels, but
were increased as a proportion of peripheral T cells by adult-
hood22,26 (Supplementary Fig. 1a), resulting in an adult human
Vδ2+ T-cell repertoire that is uniformly responsive to P-Ag
metabolites (Supplementary Fig. 1b). To address whether Vδ2+
T-cell expansion from the neonatal pool is highly clonally
focused, as for Vδ1+ T cells11, we performed a TCR repertoire
analysis restricted to the Vδ2+ T-cell population (Fig. 1a, b).
Indicative of successful Vδ2+ γδ T-cell sorting, TCRδ repertoires
entirely comprised Vδ2 chain usage (Supplementary Fig. 1c).
Consistent with previous ﬁndings, TCRγ repertoires were pre-
dominantly composed of Vγ9 chains (Supplementary Fig. 1d)
and the joining region JγP (Fig. 1c), and neonatal Vδ2 chains
preferentially used joining region Jδ327, whereas Jδ1 was more
commonly utilised in adults28 (Fig. 1d). TCRδ-mediated
responses to P-Ag have been associated with hydrophobic
amino acid residues (LVW) at position 5 in CDR3δ2 sequences29,
and this is observed in adult Vδ2 CDR3 repertoires11. We found
that although neonatal Vδ2–Jδ3 sequences generally lacked this
motif, and overall were enriched relative to Vδ2–Jδ1 sequences
for neutral residues at position 5, particularly Gly, some
Vδ2–Jδ3 sequences contained the hydrophobic residue Leu,
whereas Vδ2–Jδ1 sequences, although rarer in neonates, were
highly enriched for hydrophobic residues at position 5 (Fig. 1e).
We next analysed Vδ2+ T-cell repertoires using approaches we
previously applied to the Vδ1+ compartment11. Tree plot analysis
revealed the presence of some relatively prominent clonotypes in
adult Vδ2 TCRγ (between 12 and 47%) and TCRδ (between 1.8
and 39%) repertoires (Fig. 1a). The ten most prevalent TCRγ
clonotypes in each donor formed a substantially smaller portion
(P= 0.003; Mann–Whitney) of the Vδ2+ T-cell repertoire (mean
40.5% of total Vδ2 reads) than expanded Vδ1 clonotypes (mean
73.42% of total Vδ1 reads11). Unlike the Vδ1 compartment,
similarly prominent clonotypes were also present in cord blood
Vδ2+ TCRγ (between 18 and 34%) repertoires (Fig. 1a, b).
Analysis of the cumulative frequency curves of the 10 most
prevalent CDR3 sequences highlighted both adult and cord blood
Vδ2+ TCR repertoires exhibit an intermediate degree of
clonotypic focusing, relative to cord blood Vδ1 (low focusing)
and clonally expanded adult Vδ1 repertoires (high focusing;
Fig. 1f). Analysis of D75 diversity metrics (the percentage of
clonotypes required to occupy 75% of TCR repertoire) high-
lighted that in Vδ2+ T-cell repertoires diversity did not generally
differ between adult and cord blood Vδ2+ repertoires (Fig. 1g and
Supplementary Fig. 1e). Moreover, Vδ2+ TCR repertoire D75
metrics were also independent of the level of diversity seen in
matched Vδ1+ TCR repertoires (Supplementary Fig. 1f). Finally,
and consistent with a broadly similar Vδ2+ repertoire in cord and
adult blood, the CDR3 length proﬁle of TCRδ and TCRγ
repertoires were highly comparable between cord blood and adult
(Fig. 1h). Therefore, while some variability in the level of focusing
is observed in both settings, the neonatal and adult
Vδ2+ repertoires are broadly similar in diversity, in terms of
both accumulated clonotype frequency, D75, and CDR3 length
analysis.
Public Vγ9+ CDR3s span adult and neonatal Vδ2+ T cells. Due
to the largely similar Vδ2+ repertoire characteristics found in
cord blood and adult, we next assessed the proportion of CDR3
amino acid sequences that were “public”, i.e., detected in more
than one donor. Consistent with a high degree of diversity within
the TCRδ repertoire, adult TCRδ2 repertoires contained few
shared CDR3δ sequences (mean 8.7%), although this proportion
was increased in cord blood CDR3δ repertoires (mean 36.8%;
Fig. 2a, Supplementary Table 1 and 2). However, a mean 79.3% of
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04076-0
2 NATURE COMMUNICATIONS |  (2018) 9:1760 | DOI: 10.1038/s41467-018-04076-0 |www.nature.com/naturecommunications
the CDR3γ9 amino acid sequences present in a given individual
were shared with at least one other adult or cord blood
donor (Fig. 2b). Moreover, the majority of sequences in cord
blood were directly shared in adult repertoires (Fig. 2c),
indicating a core set of CDR3γ9 sequences in adult donors
essentially indistinguishable from equivalent unrelated neonatal
donor sequences.
To further explore this publicity, we examined the 10 most
prevalent CDR3γ9 sequences from our cohort (see Methods),
representing a mean 38.9% of the total CDR3γ9 repertoire
(Fig. 2d). This highlighted a set of public CDR3γ9 sequences that
were prevalent in both adult and cord blood repertoires, and at
similar frequencies (Fig. 2d). Notably, two simple CDR3γ9
sequences were prevalent in all adult and neonatal repertoires
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analysed: CALWEVQELGKKIKVF (mean 13.1% in adult, and
mean 24.6% in neonates) and CALWEVRELGKKIKVF (mean
4.3% in adults and mean 5.4% in neonates). Two processes
explain the high degree of sharing within the CDR3γ9 repertoire.
Firstly, single-cell TCR sequencing highlighted that CALWEV-
QELGKKIKVF could be generated by simple recombination of
Vγ9 and JγP gene segments containing no added N nucleotides
(“germline”) (Table 1). This sequence was common in foetal
liver30, and foetal blood25 and observed to persist into
adulthood31. While a high prevalence in repertoire data might
indicate an expanded clonotype, single-cell TCR analysis also
revealed that this germline-encoded CDR3γ9 sequence in fact was
comprised of multiple TCR “pseudoclonotypes”, in which the
same CDR3γ9 was independently generated and paired with
different CDR3δ2 sequences in the same individual (Table 1).
Secondly, CDR3γ9 sequences such as CALWEVQELGKKIKVF
and CALWEVRELGKKIKVF could also be generated by
convergent recombination, whereby variable degrees of exonu-
clease activity and N nucleotide addition result in the generation
of the same CDR3γ amino acid sequences from different
nucleotide sequences (Table 1). Both of these processes explain
why CDR3γ9 repertoires were less diverse compared to CDR3δ
repertoires (Fig. 2e), and are consistent with the generation of
public TCR sequences32, but importantly, these mechanisms are
not evident in Vδ1+ TCRγ repertoires11.
Altered Vγ9+ Vδ2+ T-cell phenotype links to clonal expansion.
We evaluated the memory phenotype of Vδ2+ T cells from each
donor to establish the relationship with TCR clonotype. Adult
Vγ9+ Vδ2+ T cells from healthy donors (16/18 of total donors, 5/
7 TCR repertoire study donors) regularly display a major CD27+
CD45RA− phenotype (similar to Central Memory (CM) CD8+
αβ T cells) and a minor CD27− CD45RA− phenotype (similar to
Effector Memory (EM) CD8+ αβ T cells) (Fig. 2f), consistent
with other studies33. Importantly, Vγ9+ Vδ2+ T cells differ from
Vδ1+ T-cell populations in their expression levels of CD27
(Fig. 2g) and distinct naive and effector T-cell surface marker
expression (Fig. 2h).
Although overall our adult cohort displayed similar Vγ9+
Vδ2+ TCR diversity to cord blood samples, two adult donors (6
and 24) appeared to exhibit a degree of clonotypic focusing, based
on their low D75 values for both TCRγ (mean 2.9) and TCRδ
(mean 5.0) combined with their higher cumulative frequency of
the 10 most prevalent clonotypes (mean 60.5% of TCRγ and
mean 50.3% of TCRδ) (Fig. 1a). Consistent with this, each donor
displayed individual clonotypes with a similar ampliﬁed
frequency in both TCR γ and δ repertoires (Fig. 1a). Both donor
6 and 24 each possessed a distinct uncommon but shared
sequence, CALWEVRKELGKKIKVF (detected in donor 6 and
also in 2 other donors) or CALWEKMQELGKKIKVF (detected
in donor 24 and in 4 other donors), usually outside the top 10
most prevalent shared clonotypes, but now representing 18.5%
(donor 6) and 44.6% (donor 24) of the TCRγ9 repertoire,
respectively (Fig. 2d). Also, donor 6 possessed a common
sequence found in all donors, CALWETQELGKKIKVF, normally
accounting for a mean 0.95% of the TCRγ9 repertoire, but
increased to 22.9% of donor 6’s TCRγ9 repertoire (Fig. 2d).
Furthermore, these unusual clonal ampliﬁcations were linked to
phenotypic changes in the total Vγ9+ Vδ2+ T-cell population,
whereby these donor’s cells adopted a predominant CD27−
CD45RA− phenotype (Fig. 2i). These data suggest that
despite the public repertoire and associated dominant phenotype
(CD27+ CD45RA−) in the majority of donors, there is scope
within the Vγ9+ Vδ2+ TCR repertoire for a degree of speciﬁc
clonal ampliﬁcation, alongside concomitant phenotypic changes.
A discrete Vγ9− Vδ2+ subset persists from birth into adults.
TCR γ repertoire datasets from Vδ2+ T cells were dominated by
Vγ9 TCR sequences, but we noted the presence of non-Vγ9 (i.e.,
Vγ2–8) sequences in adult TCRγ repertoires (mean 4.46%)
(Fig. 3a). Although such chain usage could conceivably represent
second productive TCRγ rearrangements in Vγ9+ Vδ2+ T cells,
an alternative possibility was that they reﬂected the existence of
an unusual Vγ9− Vδ2+ T-cell subset that may persist in adult-
hood. As Vγ9− TCR usage by neonatal Vδ2+ T cells has been
previously reported34, we established ﬂow cytometry-based
identiﬁcation of Vγ9− cells in cord blood Vδ2+ T cells
(Fig. 3b) and quantiﬁed their relative frequency (mean 32.41%)
(Fig. 3c). Importantly, adult Vδ2+ T-cell pools retained this Vγ9−
subset at low frequency (mean 4.82%) (Fig. 3c and Supplementary
Fig. 2a), but on average occupying a similar frequency within total
peripheral blood T cells to that of α-GalCer/CD1d reactive nat-
ural killer T cells (NKT) (Fig. 3d and Supplementary Fig. 2b).
Notably, the identiﬁcation of Vγ9−Vδ2+ T cells was only possible
with the use of an anti-Vδ2 TCR antibody clone, 123R3 (Milte-
nyi), while this population was undetectable using another TCR
Vδ2 antibody clone, B6 (Biolegend), which is likely to be speciﬁc
for the Vγ9+ Vδ2+ TCR pairing (Fig. 3e).
Vγ9− Vδ2+ T cells and Vγ9+ Vδ2+ T cells are distinct. As adult
peripheral blood Vδ2+ T cells are commonly responsive to host
and microbial P-Ags, we assessed the proliferative capacity of
Vγ9− Vδ2+ T cells towards microbial P-Ag (HMB-PP). While
CD8+, both Vδ2+ subsets and Vδ1+ T cells all proliferated in
response to anti-CD3/CD28 stimulation, only Vγ9+ Vδ2+ T cells
responded to HMB-PP (Fig. 3f). We then compared the memory
phenotype of Vγ9+ Vδ2+ T cells to other human γδ T-cell
Fig. 1 Adult and cord blood Vδ2+ TCR repertoires are broadly similar. a Tree maps show each adult donor’s Vδ2+ TCR repertoire, with each CDR3
clonotype as a coloured segment (each coloured CDR3 segment is chosen randomly and does not match between plots) plotted in relation to the total
repertoire size and accompanying clonotype frequency graphs showing the individual clone frequency (left y axis) and the accumulated frequency for the
10 most prevalent clonotypes (right y axis). Inset into each graph are D75 repertoire diversity metrics (measuring the percentage of clonotypes required to
occupy 75% of the total TCR repertoire). b Tree maps showing TCR γ and δ CDR3 clonotypes, accumulated frequency graphs and D75 metric from cord
blood Vδ2+ T cells. c Jγ and d Jδ segment usage in Vδ2+ TCR repertoires from adult peripheral blood (n= 7) and cord blood samples (n= 4). e Logo
analysis of amino acid enrichment at each position in neonatal Vδ2–Jδ1 CDR3δ (left) and Vδ2–Jδ3 CDR3δ (right) sequences. Analysis was conﬁned to the
10 most abundant CDR3δ2 sequences of 13–16 amino acid length. The different amino acids are coloured according to physicochemical properties (acidic
(red); basic (blue); hydrophobic (black); and neutral (green)). Red arrows indicate position 5 in the CDR3 sequence (see Methods section).
f Comparison of accumulated frequency curves generated from the 10 most prevalent TCRγ (left) and δ (right) clonotypes in Vδ2+ and Vδ1+ TCR
repertoires (Vδ1 cohort data analysed from11) from adult peripheral blood (Vδ2+, n= 7 and Vδ1+, n= 13) and cord blood (Vδ2+, n= 4 and Vδ1+, n= 5).
g Comparison of TCRγ D75 metrics from adult peripheral blood and cord blood Vδ2+ (adult: n= 7; cord blood: n= 4) and Vδ1+ repertoires (adult focused:
n= 13; adult diverse: n= 7; cord blood: n= 5). h Comparison of the CDR3 length proﬁles in Vδ2+ TCRδ and γ repertoires from adult peripheral blood
(n= 7) and cord blood (n= 4). Error bars indicate means ± SEM; **P < 0.01; ***P < 0.001; p-values were determined by Student's t-test (g: left) and
Kruskal–Wallis test (ANOVA) with Tukey’s post hoc testing (g: right). NS not signiﬁcant
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populations. Cord blood Vγ9− Vδ2+ T cells expressed a CD27hi
phenotype which extended to the adult population, remarkably
similar to naive-like Vδ1+ T cells (Fig. 3g). We next assessed the
expression of naive and effector T-cell markers in paired γδ T-cell
populations from the same donors. Vγ9− Vδ2+ T cells
commonly displayed lower levels of TCR Vδ2 expression and
higher levels of CD27 expression than their Vγ9+ counterparts
(Fig. 3h). Vγ9− Vδ2+ T cells expressed the lymphoid homing
receptor CCR7, the homoeostatic cytokine receptor IL7Rα
(Fig. 3i) but lacked the cytotoxic effector molecule Granzyme
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(Grz) A or the endothelial homing receptor CX3CR1 (Fig. 3j),
with these expression patterns contrasting with Vγ9+ Vδ2+
T cells (Vδ2hi CD27int CCR7− IL7Rα+ Grz A+ CX3CR1+) but
together highly similar to CD27hi Vδ1+ T cells (Fig. 3h–j).
Moreover, Vγ9− Vδ2+ T cells were responsive to CD3/
CD28 stimulation, but like Vδ1 T cells were unresponsive to IL-
12/IL-18 (Fig. 3k), whereas Vγ9+ Vδ2+ T cells were responsive to
both CD3/CD28 and IL-12/IL-1811. CD27hi Vδ1+ T-cell popu-
lations lack expanded clonotypes and possess a diverse and pri-
vate TCR repertoire11. Analysis of the publicity of adult Vγ9−
Vδ2+ TCR repertoires indicated a far more private TCRγ
repertoire compared to Vγ9+ Vδ2+ T cells (Fig. 3l), but
equivalent to the highly private Vδ1+ TCR repertoire11. This was
conﬁrmed by single-cell TCR sequencing of adult Vγ9− Vδ2+
T-cell populations, which contained diverse TCR sequences,
comprising a range of Vγ chains (Fig. 3m), and featuring TCR γ
and δ chains that each lacked motifs previously linked to P-Ag
reactivity (Table 2). In contrast, Vγ9+ Vδ2+ T cells sorted from
the same donors displayed sequences that included prevalent
shared TCRγ sequences (Fig. 3m and Table 1). Collectively, these
data suggest that the Vγ9− Vδ2+ subset is functionally,
phenotypically and clonotypically distinct from its Vγ9+
counterparts, but may share a similar biology to that of Vδ1+
T cells.
Vγ9− Vδ2+ T cells clonally expand into effectors. Within our
healthy donor cohort, one individual (“donor X”) had a sub-
stantially increased Vγ9− Vδ2+ T-cell population, comprising
1.2% of all CD3+ T cells (Fig. 4a), far higher than the 17 other
healthy donors (mean 0.13% of CD3+ T cells). Importantly, and
in contrast to the dominant CD27hi phenotype displayed by
Vγ9− Vδ2+ T cells in all other healthy donors, “donor X’s” Vγ9−
Vδ2+ T-cell population had downregulated CD27 and retained
CD45RA expression (CD27lo/neg phenotype), now accounting for
91.4% of the Vγ9− Vδ2+ T-cell population (Fig. 4a). We next
carried out single-cell TCR sequencing to determine if any par-
ticular γδ TCR clonotypes correlated with this phenotypic
change. Strikingly, a single clone now dominated the Vγ9− Vδ2+
T-cell population (35/36 single cells sequenced), composed of a
Vδ2 CDR3 (CACGSWWGTYTDKLIF) paired with a Vγ8–JγP1
chain (Fig. 4b), and now represented the single most dominant
clonotype within the Vδ2+ T-cell repertoire (Fig. 4c). As this
dominant clonotype occurred in conjunction with a CD27lo/neg
phenotype, we assessed effector T-cell marker expression. “Donor
X’s” Vγ9− Vδ2+ T-cell population expressed the antibody-
mediated cytotoxicity receptor CD16 (FcγRIIIa), CX3CR1, Grz A
and had downregulated CCR7, in contrast to naive CD8 T cells,
but closely matching CD27lo/neg Vδ1+ T cells (Fig. 4d), which
also comprised dominant clonotypes11. These results highlight
the potential for the Vγ9− Vδ2+ T-cell compartment to undergo
clonal selection and differentiation, mimicking the transition to
clonality and effector status previously observed in Vδ1+
T cells11.
Clonally focused Vγ9− Vδ2+ T cells inﬁltrate human liver.
Vδ1+ T cells are predominantly associated with a role in tissue
immunity35,36. To address whether the Vγ9− Vδ2+ T-cell
population was also represented in solid tissues, we analysed
human liver samples for the presence of intrahepatic Vγ9− Vδ2+
T cells (Fig. 5a). While the Vδ2+ T cells in the liver comprised a
lower proportion of total CD3+ T cells than in peripheral blood,
intrahepatic Vδ2+ T cells generally contained a higher fraction of
Vγ9− cells (Fig. 5b). Phenotypic analysis of intrahepatic Vγ9−
Vδ2+ T cells revealed these cells to consistently display a CD27lo/
neg phenotype (Fig. 5c, d). Single-cell TCR sequencing analysis,
highlighted that a majority of intrahepatic Vγ9− Vδ2+ T cells
were comprised of a limited set of expanded clonotypes
(Fig. 5e and Table 2). Moreover, clonally expanded intrahepatic
Vγ9− Vδ2+ T cells expressed effector markers CX3CR1 and Grz
A but had downregulated IL7Rα (Fig. 5f).
Clonal expansion of Vγ9− Vδ2+ T cells in acute CMV infec-
tion. The clonotypic and phenotypic parallels between Vγ9−
Vδ2+ and Vδ1+ γδ T cells, combined with their strong distinc-
tion from P-Ag sensing Vγ9+ Vδ2+ T cells, prompted us to
investigate if this subset was reactive to acute cytomegalovirus
(CMV) infection, previously shown to drive the numeric37 and
clonal12 expansion of Vδ1+ T cells. We examined a cohort of ﬁve
CMV-seronegative (CMV−) patients receiving CMV-seropositive
(CMV+) kidney transplants who then went on to either develop
post-operative acute CMV infection (patient 261, 231 and 1014),
or who remained CMV− (patient 279 and 282)38. We analysed
peripheral blood samples for Vγ9− Vδ2+ T cells before and after
post-transplant CMV infection. Prior to CMV infection, at
0–4 weeks post-transplant, Vγ9− Vδ2+ T cells represented low
frequency populations in all donors (Fig. 6a and Supplementary
Fig. 3). However, following CMV infection, occurring between
5–8 weeks post-transplant, we observed the substantial expansion
Table 1 Single-cell TCR sequencing of adult Vγ9+ Vδ2+ T cells
Donor CDR3γ9 (amino acid) CDR3γ9 nucleotide (nt) sequence N nt P nt CDR3δ2 (amino acid)
3 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDSLLGDTPNFDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDTGGAQSWDTRQMFF
28 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTTCAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 0 CACDSLGTYTDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDIILGGQYTDKLIF
35 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAGGAGTTGGGCAAAAAAATCAAGGTATTT 1 2 CACESLGPTGGNPSSDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTTCAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 0 CACDTITHRTGGPQVTDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDGLGGEYTDKLIF
42 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDKVGYGSPWDTRQMFF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDTIPTGGHDPYTDKLIF
231 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTACAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 0 CACDTVTRDKGADKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTACAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 0 CACDTMGARHTDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTACAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 0 CACDTGFGLVQSHGPKRTDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDRLGGNTDKLIF
1014 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDTVPSTGGPKDTDKLIF
CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT Germline 0 CACDTGSLQRYNSWDTRQMFF
261 CALWEVRELGKKIKVF TGTGCCTTGTGGGAGGTCAGAGAGTTGGGCAAAAAAATCAAGGTATTT 3 0 CACDTWGTVGRTDKLIF
CALWEVRELGKKIKVF TGTGCCTTGTGGGAGGTGCGAGAGTTGGGCAAAAAAATCAAGGTATTT 1 1 CACDTVGDWGTPLYTDKLIF
Public TCRγ9 clonotypes and their paired TCRδ2 sequence from seven donors. Sequences were analysed using IMGT Junction Analysis, which identiﬁed V, D and J gene segments used and highlighted N
nucleotide addition (bold and italic) and P nucleotide addition (underlined). The table depicts CDR3γ9 amino acid sequence, CDR3γ9 nucelotide (nt) sequence, germline or N nt addition, P nt addition,
CDR3δ2 amino acid sequence. Hydrophobic amino acids at position 5 (see Methods section) in the CDR3δ2 sequence are highlighted in bold
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of the Vγ9− Vδ2+ T-cell population in donor 261 and 231
(Fig. 6a). Conversely, patients 282 and 279 who did not become
infected with CMV, displayed no expansion of Vγ9− Vδ2+
T cells over a 5-year period after transplantation (Supplementary
Fig. 3a). Of note is patient 1014, who became infected with CMV
but did not display an expanded Vγ9− Vδ2+ T-cell population
(Supplementary Fig. 3b), suggesting inter-individual differences
in the Vγ9− Vδ2+ T-cell response to CMV infection consistent
with observations in Vδ1+ T cells from persistently infected
CMV+ healthy adult donors11. Phenotypic analysis of Vγ9−
Vδ2+ T cells from CMV- patients 279 (Supplementary Fig. 3c)
and 261 immediately after transplant (Fig. 6b), indicated a
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CD27hi phenotype. Conversely after CMV infection, the expanded
Vγ9− Vδ2+ T-cell populations in patients 261 and 231 acquired a
dominant CD27lo/neg phenotype (Fig. 6b). This prompted us to
perform single-cell TCR sequencing of expanded Vγ9− Vδ2+
T-cell populations in donors 261 and 231, which identiﬁed the
selective expansion of dominant clonotypes after CMV infection
and evidence of continued clonotypic selection 5 years later (Fig. 6c
and Table 2). Finally, we assessed functional T-cell marker
expression in Vγ9− Vδ2+ T cells from patient 261 and 231 fol-
lowing CMV infection. Vγ9− Vδ2+ T cells from healthy donors
expressed CCR7, IL7Rα and the co-stimulatory molecule CD28,
while patient 261 and 231’s Vγ9− Vδ2+ T cells had downregulated
these markers and upregulated CX3CR1 and Grz A and B (Fig. 6d).
Expression of these effector markers occurred concurrently with
Vγ9− Vδ2+ T-cell clonal expansion at ~1 year (patient 261) and
were stable for over 5 years (patient 231) (Fig. 6c, d). These data
reveal that as for Vδ1+ T cells, Vγ9− Vδ2+ T cells exhibit a strong
relationship between clonotype and phenotype and are suggestive
of a role in adaptive antiviral immunosurveillance.
Discussion
This study sheds light on the biology of Vδ2+ T cells, highlighting
divergent Vγ9+ and Vγ9− subsets. Despite the ~ten-fold increase
in Vγ9+ Vδ2+ T-cell numbers in the ﬁrst year of life, our data
indicate that the extent of clonotypic focusing within the Vδ2-
associated Vγ9+ repertoire is broadly similar between neonatal
cord blood and adulthood. This ﬁnding contrasts with the Vδ1+
TCR repertoire, which typically displays pronounced clonotypic
focusing in adults relative to a highly unfocused neonatal reper-
toire11. In addition, our analyses reveal an underappreciated
degree of public amino acid sequences in the Vγ9 repertoire. This
degree of Vγ publicity, which relates to both recombination of
simple Vγ9 sequences (either germline encoded or with limited N
nucleotide addition) and convergent recombination, underlines
the semi-invariant nature of the Vγ9+ Vδ2+ TCR repertoire.
Importantly, using single-cell approaches public Vγ clonotypes
were shown frequently to pair with diverse Vδ2 chains within
single individuals, and, therefore, do not usually represent
expanded clonotypes. The innate-like biology of the semi-
invariant Vγ9+ Vδ2+ T-cell subset contrasts markedly with the
Vδ1+ subset, which displays clear hallmarks of adaptive immu-
nity such as clonal ampliﬁcation and differentiation from an
initially unfocused, private TCR repertoire.
Collectively, our repertoire data suggest a model involving a
multi-layered selection of Vγ9+ Vδ2+ T cells from foetal devel-
opment into adulthood. First, as previously suggested by Dimova
et al.25, we propose gestational selection of the Vγ9+ Vδ2+
subset, potentially via exposure to endogenous P-Ag (e.g., IPP)
most likely mediated by BTN3A115–17,39,40, allowing pre-
programming of a P-Ag reactive Vγ9+ Vδ2+ TCR repertoire.
In keeping with this, we observed that Vγ9 chains are heavily
enriched for the JγP segment, which is not generally present in
Vγ9 chains present in Vδ1+ TCR repertoires11; similarly the Jδ1+
CDR3δ2 repertoire in cord blood is enriched for a hydrophobic
amino acid at position 5 required for P-Ag recognition21,29, but
not in Vδ2 sequences in Vγ9− Vδ2+ T cells (see below). Second,
in the context of the reported lack of thymic output of Vδ2+
T cells after birth41, our observation that adult and cord blood
repertoires contain overlapping canonical P-Ag-sensing
Vγ9 sequences strongly indicates there is polyclonal post-natal
expansion of this pre-selected repertoire, most likely in response
to microbial P-Ag exposure11. However, our observation that
cord blood Vδ2 sequences generally utilised Jδ3 segments (also
observed in foetal γδ T cells,42), whereas adult Vδ2 sequences
preferentially used Jδ1 segments, suggests that post-natal micro-
bial exposure may impose some constraints on the TCR reper-
toire that differ from those required in gestation. Of note,
Vδ2–Jδ1 sequences typically contain a hydrophobic amino acid
previously highlighted as important for Vγ9+ Vδ2+ T-cell reac-
tivity to microbially-derived P-Ag21,29 whereas this is less con-
served in Vδ2–Jδ3. This might imply Vγ9+ Vδ2+ T cells bearing
Jδ1 clonotypes preferentially respond to microbial P-Ag after
birth compared to Jδ3 clonotypes, a possibility which future
studies can address. Finally, although most individuals’ Vγ9+
Vδ2+ T cells were dominated by public Vγ9 sequences and
associated with a common central memory phenotype, our
observation that a minority of individuals exhibit ampliﬁcation of
unusual public clonotypes, concomitant with adoption of an
effector memory phenotype, most likely reﬂects a third level of
selection that imparts a degree of plasticity in this fundamentally
innate-like paradigm. This observation extends previous work by
Ryan et al.33 indicating that further functional and transcriptional
changes are linked to an effector memory phenotype in Vγ9+
Vδ2+ T cells. Therefore, the semi-invariant Vγ9+ Vδ2+ reper-
toire may provide scope for selective TCR-mediated responses to
microbial P-Ag. Importantly, our model shares a number of
features with MAIT cells, a semi-invariant population that is also
subject to both gestational selection (through interactions with
MR1) and post-natal expansion in response to microbial infec-
tion/colonisation43, and that displays clonotype-speciﬁc respon-
ses to metabolite ligands44 and microbial species45.
Our analyses also highlight a population of Vγ9− Vδ2+ T cells
that is highly distinct from the Vγ9+ Vδ2+ P-Ag-reactive subset,
and present in all adult peripheral blood and cord blood,
where they commonly exist as a CD27hi, TCR diverse subset
phenotypically equivalent to naive-like Vδ1+ T cells. We note this
distinction based on Vγ9 chain usage cannot be applied to the γδ
T-cell compartment as a whole, as the Vδ1+ T-cell subset, which
appears to exhibit an adaptive immunobiology, contains a
Fig. 3 Vγ9− Vδ2+ T cells are clonally and phenotypically distinct from Vγ9+ Vδ2+ T cells. a Frequency of Vγ9 chain usage in Vδ2+ TCR repertoire
sequencing data from adult peripheral blood (n= 7). b Identiﬁcation of Vδ2+ T cells in CD3+ T cells (left) and Vγ9− cells within Vδ2+ T cells (right) from
cord blood (n= 5). c Frequency of Vγ9− and Vγ9+ cells in Vδ2+ T cells from cord blood (left; n= 5) and adult peripheral blood (right; n= 18). d Frequency
of Vγ9− Vδ2+ T cells (n= 18) and NKT cells (αGalcer/CD1d+; n= 5) in adult peripheral blood. e Vγ9− Vδ2+ T cells identiﬁed by TCR Vδ2 antibody clones
(B6 and 123R3) in matched adult peripheral blood donors (n= 5). f Proliferation by CFSE dilution of CD8+ αβ and γδ T-cell populations from PBMC treated
with medium alone, 10 nM HMB-PP or 5 μg/ml anti-CD3/CD28 (n= 5). g CD27 and CD45RA T-cell memory marker expression proﬁles on Vγ9− Vδ2+
and Vδ1+ T cells from adult peripheral blood (top row: Vδ2, n= 14; Vδ1, n= 14) and cord blood (bottom row: Vδ2 and Vδ1, n= 5). h Vδ2+ TCR and CD27
expression levels, i naive and j effector T-cell marker expression on donor matched γδ T-cell populations from adult peripheral blood (n= 3). k Sorted
CD3+ T cells were incubated for 72 h with cytokines or anti-CD3/CD28 beads. Vγ9− Vδ2+ T cells were then assessed for the upregulation of CD25
(n= 3). l Comparison of CDR3γ sequence sharing in γδ T-cell repertoires from adult peripheral blood (Vδ1, n= 20; Vδ2, n= 7) and cord blood (Vδ1, n= 5;
Vδ2, n= 3). m CDR3γ sequence analysis of single cell sorted Vγ9+ and Vγ9− Vδ2+ T cells, public sequences are coloured (black, shared sequences from
deep sequencing); graph shows Vγ usage of Vγ9− Vδ2+ TCR sequences from each donor. Error bars indicate means ± SEM; **P < 0.01; ***P < 0.001;
****P < 0.0001; p-values were determined by paired t-test (e), RM two-way ANOVA with Tukey’s post hoc testing (f); one-way ANOVA with Tukey’s post
hoc testing (h, i) or Dunnett’s post hoc testing (j, k)
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sizeable portion of Vγ9+ T cells11. Moreover, consistent with a
distinct biology for Vγ9 chains in these two contexts, the Vγ9
CDR3 sequences associated with Vδ1 chains did not utilise JγP
sequences and were highly distinct from those associated with
Vδ2 chains11. Consistent with expression of TCRγ and TCRδ
sequences divergent from the Vγ9+ Vδ2+ subset, the Vγ9− Vδ2+
population was not P-Ag responsive. Thus, Vγ9− Vδ2+ T cells
represent a universal γδ subset that is clonotypically, phenoty-
pically and functionally divergent from Vγ9+ Vδ2+ T cells.
Moreover, as evidenced from a single unusual peripheral blood
donor and several liver samples, Vγ9− Vδ2+ T cells appeared
capable of undergoing an adaptive-like programme of highly
Table 2 Single-cell TCR sequencing of Vγ9− Vδ2+ T cells
Donor CDR3δ2 Dδ Jδ CDR3δ length Vγ Jγ CDR3γ length
3 CACGSWWGTYTDKLIF 1,3 1 14 8 P1 11
231 CACDTIVGDTLTDKLIF 3 1 15 8 P1 9
CACVRGGGYPRGADKLIF 3 1 16 8 1/2 14
CACDTEGEVNTDKLIF 3 1 14 4 P1 11
261 CACDTRFRPGRSARVVRLTAQLFF 1 2 22 3 P1 14
Liver 1 CACSREQAHTDKLIF 3 1 13 3 1/2 10
CACDTGWGIRGRYTDKLIF 3 1 17 4 1/2 11
Liver 2 CACDRSGARWDKLIF — 1 13 5 1/2 10
42 CACDARHYWGISTDKLIF 3 1 16 2 1/2 12
CACDARLGEHTDKLIF 3 1 14 ND ND ND
CACDRMGDLPSSWDTRQMFF 3 3 18 3 1/2 13
CACGSSWGVSHYTDKLIF 3 1 16 5 1/2 10
CACDLLGDFRTDKLIF 3 1 14 8 1/2 8
CACSVRGHWGRSTDKLIF 3 1 16 8 1/2 14
CACDTRGIGDTLPDKLIF 3 1 16 8 P1 12
CACAHGYWGTPWDTDKLIF 3 1 17 3 P1 11
CACDTGDTDTDKLIF 3 1 13 8 P1 13
CACDRLLLGDTDKLIF 3 1 14 ND ND ND
CACDTRRTGGRDKLIF 3 1 14 5 1/2 9
CACDKRIRWGNPYTDKLIF 3 1 17 8 P2 10
CACEVPSYEPYWGTKKYTDKLIF 2,3 1 21 3 1/2 11
CACDTGDWGINTDKLIF 3 1 15 8 P1 14
CACDQKYWGGSSTDKLIF 3 1 16 2 P 13
TCRδ sequences of clonally expanded Vγ9− Vδ2+ TCRs from donors expressing a CD27lo/neg phenotype (top section). All TCRδ2 sequences from a representative healthy donor with a CD27hi
phenotype (bottom section). Sequences were analysed using IMGT Junction Analysis, which identiﬁed V, D and J gene segments used. The table depicts CDR3δ sequences, Dδ usage, Jδ usage, CDR3
length, Vγ usage, Jγ usage and CDR3γ length. Amino acids (aa) at position 5 of the CDR3 sequence (see Methods) are highlighted in bold. ND not determined
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focused clonotypic expansion and concomitant phenotypic dif-
ferentiation that closely matches that of Vδ1+ T cells but is not
observed in Vγ9+ Vδ2+ T cells. This considerably extends the
ﬁndings of Ravens et al.12, who detected unusual Vγ9− Vδ2+
clonotypes in the peripheral blood of one healthy donor and one
HSCT recipient.
This adaptive biology was conﬁrmed by our analysis of patients
following acute CMV infection, which highlighted a striking
expansion of the Vγ9− Vδ2+ subset after infection, linked to the
selection of dominant clonotypes, which occurred concomitantly
with differentiation from a naive CD27hi to a CD27lo/neg phe-
notype, and acquisition of CX3CR1 and cytotoxic granzymes,
similar to CMV-speciﬁc cytotoxic CD8+ T cells46,47. Interest-
ingly, the single healthy donor who exhibited a clonally expanded
Vγ9− Vδ2+ T-cell subset (“donor X”) was CMV+ and unusually,
displayed elevated IgG titres, raising the possibility of recent
CMV reactivation. Our ﬁndings therefore suggest a role for the
Vγ9− Vδ2+ T-cell subset in unconventional immunosurveillance
against viral infection, and provide a clear indication that this
subset assumes an adaptive immunobiology, highly similar to that
suggested for Vδ1+ T cells11,12. These data suggest clonal selec-
tion from a CCR7+, potentially lymphoid tissue homing, naive-
like Vγ9−Vδ2+ T-cell population that expresses a pool of TCRs,
enabling ampliﬁcation of responses to microbial challenges, via
differentiation of cells bearing biologically relevant clonotypes to
an effector phenotype, resulting in long-lived, functional γδ T-cell
memory. The liver provided an attractive human model in which
to examine Vγ9− Vδ2+ T cells in solid tissues, as it functions as
an important site for clearance of both commensals and
pathogens from portal circulation, and has a high proportion of
unconventional T cells, such as MAIT cells48. Our ﬁnding that
clonally expanded effector Vγ9− Vδ2+ T cells can be recruited to
the liver suggests this subset may complement the innate-like
recognition provided by such hepatic semi-invariant T cells with an
unconventional adaptive memory response. Unfortunately, we were
unable to obtain CMV serostatus for the patients from whom
explanted liver samples were derived, and therefore unable to
conclude if the presence of such hepatic Vγ9− Vδ2+ T cells solely
reﬂected CMV seropositivity or alternatively a wider set of immune
challenges. Of relevance, a monoclonally expanded myocytotoxic
T-cell population bearing a Vγ3+ Vδ2+ TCR detected in a patient
with polymyositis highlights the potential of the Vγ9− Vδ2+ T-cell
subset to trigger autoimmunity49,50. Further studies are required to
deﬁne additional microbial and non-microbial challenges that
stimulate this unconventional T-cell subset.
In addition to clonal expansion in response to CMV, the
ﬁnding that peripheral blood Vγ9− Vδ2+ T cells were TCR
responsive but unresponsive to IL-12/IL-18 is another feature that
distinguishes them from Vγ9+ Vδ2+ T cells, and one that again
aligns them closely with the Vδ1+ T-cell subset, which has also
been highlighted to display adaptive features11,12 Further studies
on such adaptive subsets (Vδ1+ and Vγ9− Vδ2+ T cells), ideally
ultimately in the context of physiological TCR ligands, are
required to explore the full range of functional differences with
innate-like subsets. Of note, Vγ9+ Vδ2+ T cells have previously
been demonstrated to exert pleiotropic effector functions in
response to cognate P-Ag ligands and different cytokine stimu-
lation51. Moreover, recent studies in mice highlight that γδ TCR
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triggering of innate-like lymphocytes induced a state of TCR
hyporesponsiveness in which T-cell activation could be induced
by TCR-extrinsic stimuli6 Unfortunately, a systematic compar-
ison of the TCR responsiveness of naive vs. effector Vγ9− Vδ2+
T cells within one tissue was not possible, due to the strong
dominance of naive Vγ9− Vδ2+ T cells in peripheral blood and
effector Vγ9− Vδ2+ T cells in liver. However, importantly within
the Vδ1+ T-cell compartment, CD27lo/neg effectors display a far
quicker response to TCR stimulation than CD27hi naive cells11.
This observation emphasises the strong distinction between
innate-like and adaptive subsets within the γδ T-cell
compartment.
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Human Vδ2+ T cells therefore comprise two separate subsets,
which reﬂect distinct paradigms in human γδ T-cell biology and
also have distinct roles in antimicrobial immunity. Vγ9+ Vδ2+
T cells appear to represent an innate-like subset, most likely
originating via gestational selection, which is ‘pre-armed’ from
birth with a semi-invariant TCR repertoire that includes a high
level of public Vγ TCR chains, permitting polyclonal TCR-
mediated responses to microbial P-Ag, as well as to innate
cytokines independently of the TCR. However, the Vγ9+ Vδ2+
TCR repertoire diversity may provide the potential for clonotype-
speciﬁc responses potentially targeted at speciﬁc microbial anti-
genic challenges. In contrast, Vγ9− Vδ2+ T cells, which are P-Ag-
unreactive, represent a previously ill-deﬁned unconventional T-
cell compartment that exhibits many of the key hallmarks of an
adaptive immunobiology, including clonal expansion and differ-
entiation to effector lymphocytes from an initially naive-like and
TCR diverse T-cell pool, including in response to acute viral
infection. In doing so, Vγ9− Vδ2+ T cells most likely contribute
to both peripheral blood and tissue immunosurveillance.
Methods
Ethical approval and samples. Peripheral blood samples were obtained from
healthy donors who had provided written informed consent for sample collection
and subsequent analysis; project approval for this aspect of the study was granted
by the NRES Committee West Midlands ethical board (REC reference 14/WM/
1254). Samples from patients undergoing renal transplantation were obtained at
the Academic Medical Centre, Amsterdam; the medical ethics committee of the
Academic Medical Center, Amsterdam, approved this arm of the study and all
subjects provided written informed consent in accordance with the Declaration of
Helsinki. Longitudinal heparinized blood samples were collected from CMV-
seronegative patients who developed primary CMV infection after receiving a renal
transplant from a CMV-seropositive donor. As controls, longitudinal PBMC from
age matched CMV-seronegative patients who remained CMV-seronegative during
the ﬁrst 5 years following renal transplantation were used. All patients were EBV-
seropositive. The course of CMV infection was followed by longitudinal 2-weekly
PCR for CMV viral load, and seroconversion was conﬁrmed by detection of CMV-
speciﬁc IgM and IgG. The patients did not receive CMV prophylaxis, but once the
CMV load reached 10-4 copies/ml, the MMF dose was halved and Valcyte was
given. Only patient 1014 experienced CMV-related symptoms: CMV gastritis. All
but one patient were treated with a basic immunosuppressive regimen comprising
of CD25 mAb (basiliximab) induction treatment, prednisolone, cyclosporine A and
MMF. Patient 261, however, was treated with one dose of prednisolone upon
transplantation with a kidney from an identical twin, whereafter all immunosup-
pression was ceased. Liver inﬁltrating T cells were isolated from explanted diseased
human liver tissues from patients undergoing liver transplantation for inﬂamma-
tory liver diseases, including primary biliary cholangits, primary sclerosing cho-
langitis, alcoholic liver disease, and autoimmune hepatitis (Local Research Ethics
Committee reference no. 98/CA5192) or normal liver samples from donor liver
tissue surplus to clinical requirements (Local Research Ethics Committee reference
no. 06/Q2708/11). Umbilical cord blood units were obtained from the Anthony
Nolan Cell Therapy Centre Nottingham (ANCTC) under generic tissue bank ethics
held by ANCTC and extended to the researchers under a material transfer
agreement (MTA).
T-cell isolation, culture and activation. PBMC were isolated from heparinised
venous blood by lymphoprep© (Stem Cell Technologies) density gradient cen-
trifugation as per the manufacturers instructions. For proliferation of T cells,
PBMC were labelled with 0.3 µM carboxyﬂuorescein succinimidyl ester (CFSE)
(eBioscience) and cultured with 10 nM HMB-PP (Sigma) or CD3/CD28 T activator
beads (Invitrogen) for 7 days in RPMI-1640 medium (Invitrogen) supplemented
with 2 mM L-glutamine, 1% sodium pyruvate, 50 μg/ml penicillin/streptomycin
(Invitrogen) and 10% fetal calf serum (Sigma).
Antibodies and ﬂow cytometry. For total and single-cell sorting of Vδ2+
populations, PBMC were labelled with anti-CD3 (UCHT1; Biolegend; 1:100), TCR
αβ (BW242/412; Miltenyi; 1:200), TCR Vδ2 (123R3; Miltenyi; 1:200), CD27 (M-
T271; 1:200), CD45RA (HI100; 1:200); both Biolegend, and populations were
sorted on an ARIA III Fusion (BD) (Supplementary Fig. 4a). For repertoire ana-
lysis, Vδ2+ T-cell populations were sorted directly into RNAlater (Sigma). For
phenotypic analysis, freshly isolated or frozen PBMC, or cultured cells were
labelled with Zombie Aqua viability dye (Biolegend), and then subsequently stained
(Supplementary Fig. 4b) for cell surface antigens with antibodies directed against
CD3 (UCHT1 or HIT3a; 1:100), CD8 (SK1; 1:200), CD45RA (HI100; 1:200), CD27
(M-T271; 1:200), CCR7 (G043H7; 1:50), IL7Rα (A019D5; 1:100), CD28 (28.2;
1:100), CX3CR1 (2A9-1; 1:100), CD16 (3G8; 1:150), CD69 (FN50; 1:100), TCR Vδ2
(B6; 1:100), TCR αβ (IP26; 1:50); all Biolegend. TCR Vγ9 (IMMU360; 1:400);
Beckman Coulter. TCR Vδ1 (REA173; 1:200) and TCR Vδ2 (123R3; 1:200); Mil-
tenyi, or αGalCer loaded CD1d dextramers (ProImmune; 1:20). For intracellular
staining, after surface antibody staining cells were ﬁxed in IC Fixation buffer
(eBioscience) and stained in Permeabilisation Buffer (eBioscience) with antibodies
directed against Granzyme A (CBO9; 1:100) and Granzyme B (GB11; 1:100);
Biolegend). Cells were acquired on an LSR Fortessa X20 (BD) and data analysed
with FlowJo V10.2 (TreeStar).
TCR repertoire analysis. RNA was puriﬁed from sorted cells (adult Vδ2+: 25,000
cells; cord blood Vδ2+: 2,400 - 8,800 cells) using an RNAmicro plus kit (Qiagen)
according to the manufacturer’s instructions. For high throughput deep sequencing of
γδ TCRs, we used amplicon rescued multiplex (ARM)-PCR and a MiSeq (Illumina)
next-generation sequencer (NGS)52 to analyse all sorted Vδ2+ T-cell populations. As
detailed in patent WO2009137255A2, a modiﬁed version of a protocol devised by
Han et al.53 was used, involving initial ﬁrst-round RT-PCR using high concentrations
of gene-speciﬁc primers, followed by use of universal primers for the exponential
phase of ampliﬁcation, allowing deep, quantitative and non-biased ampliﬁcation of
TCR γ and TCR δ sequences. All cDNA synthesis, ampliﬁcation, NGS library pre-
paration and sequencing were performed by iRepertoire, Inc. (Huntsville, USA). We
analysed positively sorted αβ TCR- Vδ2+ γδ T cells from 7 healthy donors and 4
umbilical cord blood units (Anthony Nolan Trust, Nottingham).
Single-cell TCR sequencing. PBMC were labelled as above and Vδ2+ T cells were
single cell sorted directly into individual wells in a 96-well plate containing 2 µl of
Superscript VILO cDNA synthesis kit reaction mix (ThermoFisher) containing
0.1% Triton X-100, and incubated according to manufacturer’s instructions. TCRγ
and TCRδ cDNAs were ampliﬁed by two rounds of nested PCR using GoTaq
mastermix (Promega) and primers for Vδ2, TCTGGGCAGGAGTCATGT
(external) and GAAAGGAGAAGCGATCGGTAAC (internal); for Cδ GCAGGA
TCAAACTCTGTTATCTTC (external) and TCCTTCACCAGACAAGCGAC
(internal); for Vγ1–8 CTGGTACCTACACCAGGAGGGGAAGG (external) and
TGTGTTGGAATCAGGAVTCAG (internal); for Vγ9 AGAGAGACCTGGTG
AAGTCATACA (external) and GGTGGATAGGATACCTGAAACG (internal)
and for Cγ CTGACGATACATCTGTGTTCTTTG (external) and AATCGTGTT
GCTCTTCTTTTCTT (internal). PCR products were separated on 1.2% agarose
gels, and products of successful reactions were incubated with ExoSAP-IT PCR
cleanup enzyme (Affymetrix) before sequencing with BigDye Terminator v3.1
(Applied Biosystems) following manufacturer’s instructions and running on an
ABI 3730 capillary sequencer (Functional Genomics Facility, University of
Birmingham).
TCR repertoire data analysis. V, D and J gene usage and CDR3 sequences were
identiﬁed and assigned and tree maps generated using iRweb tools (iRepertoire,
Inc, Huntsville, AL, USA)54. Tree maps show each unique CDR3 as a coloured
rectangle, the size of each rectangle corresponds to each CDR3s abundance within
the repertoire and the positioning is determined by the V region usage. To
determine the 10 most prevalent shared CDR3γ9 sequences, the ﬁrst 10 most
dominant sequences by frequency were ﬁltered from each donors CDR3γ9 protein
lists. These sequences were then ordered by frequency for sequences that were
shared between >2 donors (to create a hierarchy of 10 common sequences) and
uncommon highly ampliﬁed sequences were included in the ﬁnal analysis. For
more detailed analysis of the TCR repertoire, datasets were processed using the
MiXCR software package55 to further correct for PCR and sequencing errors.
Diversity metrics, clonotype overlap and gene usage were plotted in R, by
VDJTools56.
Fig. 6 Vγ9− Vδ2+ T cells exhibit TCR-speciﬁc clonal expansion in response to viral infection. a Identiﬁcation of Vδ2+ T cells in CD3+ T cells (top row) and
Vγ9− cells within Vδ2+ T cells (bottom row) in longitudinal peripheral blood samples from two CMV-seronegative kidney transplant patients developing
post-operative acute CMV infection (CMV-seroconversion: patient 231, 8 weeks; patient 261, 7 weeks). b CD27 and CD45RA T-cell memory marker
expression proﬁles by detectable Vγ9− Vδ2+ T cells populations in longitudinal peripheral blood samples from patients 231 and 261. Cytometry data from
patient 261 at 281 weeks was acquired on an alternative ﬂow cytometer (a and b). c Single-cell CDR3δ sequence analysis and Vγ usage by Vγ9− Vδ2+
T cells sorted from patients 231 and 261 peripheral blood samples between 39 and 328 weeks after transplantation. d Analysis of the indicated naive and
effector T-cell markers by Vγ9− Vδ2+ T cells from patients 261 (week 48) and 231 (week 328) and in comparison with CD27hi, CD27lo/neg Vδ1+ and Vγ9−
Vδ2+ T cells from the peripheral of blood of two healthy donors analysed in parallel. ND no detectable population
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TCR sequence analyses. The CDR3 sequence was deﬁned as the amino acids
between the second Cysteine of the V region and the conserved Phenylalanine of
the J region, according to IMGT. CDR3 sequences shown in tables include the
conserved Cysteine and Phenylalanine, but only the amino acids between these
residues are counted for CDR3 length analysis and for analysis of residues at
position 5. N and P nucleotides were identiﬁed using the IMGT Junction Analysis
tool57,58. Neonatal Vδ2 sequence logos were generated on the Seq2Logo server59 in
Shannon format without the use of pseudo counts, and give a visual representation
of amino acids enriched at different positions in the observed CDR3δ2 sequences.
The different amino acids are coloured according to physicochemical properties
(acidic (DE), red; basic (RKH), blue; hydrophobic (ACFILMPVW), black; and
neutral (NSGTY), green). For TCRδ2 sequences, the ten most abundant clonotypes
of 14–16 amino acids using either Jδ3 or Jδ1 from each donor were aligned using
Clustal Omega52 with default parameters, before logo generation. Narrower bars in
the sequence logo correspond to gaps in the sequences.
Statistical analysis. Each data set was assessed for normality using Shapiro–Wilk
normality test. Differences between columns were analysed by two-tailed Student’s
t-tests for normally distributed data and Mann–Whitney for non-parametric data.
Differences between groups were analysed using one-way ANOVA with Dunnett’s
or Tukey’s post tests for normally distributed data or with Kruskal–Wallis with
Tukey’s post tests for non-parametric data and RM two-way ANOVA with Tukey’s
post tests was used when comparing groups with independent variables. *P < 0.05,
**P < 0.01, ***P < 0.001 and ****P < 0.0001. Correlation was assessed for non-
parametric data by Spearman correlation. Tabulated data were analysed in
Graphpad PRISM 7 (Graphpad Software, Inc.).
Data availability. All data are available from the authors upon request. The
sequence data that support the ﬁndings of this study have been deposited in the
NIH NCBI sequence read archive (SRA) database with the primary accession code
SRP113556 and SRP096009, for Vδ2+ and Vδ1+ TCR repertoires respectively.
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